Table 3. Interaction between maternal passive smoking during pregnancy and single genotype of CYP1A1 and GSTs on risk of spontaneous PTD.
Passivesmoking | Genotype | Case(n = 198) | Control(n = 524) | ORa(95%CI) | P-value |
N.(%) | N.(%) | ||||
CYP1A1 Msp I | |||||
No | TT | 41 (20.7) | 151 (28.8) | 1 | |
No | TC/CC | 60 (30.3) | 218 (41.6) | 0.96 (0.61–1.52) | 0.876 |
Yes | TT | 32 (16.2) | 61 (11.6) | 1.75 (1.00–3.07)* | 0.052 |
Yes | TC/CC | 65 (32.8) | 94 (17.9) | 2.42 (1.50–3.89)* | 0.000 |
Interaction | 1.44 (0.71–2.92) | 0.319 | |||
CYP1A1 BsrD I | |||||
No | AA | 50 (25.3) | 203 (38.7) | 1 | |
No | AG/GG | 51 (23.5) | 166 (31.7) | 1.18 (0.75–1.85) | 0.483 |
Yes | AA | 45 (22.7) | 87 (16.6) | 1.98 (1.22–3.22)* | 0.007 |
Yes | AG/GG | 52 (26.3) | 68 (13.0) | 2.90 (1.78–4.72)* | 0.000 |
Interaction | 1.24 (0.62–2.47) | 0.541 | |||
GSTM1 | |||||
No | Present | 49 (24.7) | 195 (37.2) | 1 | |
No | Null | 52 (26.2) | 174 (35.7) | 1.15 (0.73–1.81) | 0.519 |
Yes | Present | 48 (24.2) | 80 (15.3) | 2.30 (1.41–3.74) | 0.001 |
Yes | Null | 49 (24.7) | 75 (29.5) | 2.43 (1.49–3.97) | 0.000 |
Interaction | 0.92 (0.46–1.83) | 0.806 | |||
GSTT1 | |||||
No | Present | 49 (24.7) | 163 (31.1) | 1 | |
No | Null | 52 (26.2) | 206 (39.3) | 0.84 (0.53–1.33) | 0.454 |
Yes | Present | 46 (23.2) | 78 (14.9) | 1.81 (1.10–2.98) | 0.020 |
Yes | Null | 51 (25.8) | 77 (14.7) | 2.22 (1.37–3.62) | 0.002 |
Interaction | 1.46 (0.73–2.91) | 0.286 | |||
GSTs | |||||
No | Present | 73 (36.9) | 267 (51.0) | 1 | |
No | Null | 28 (14.1) | 102 (19.5) | 1.00 (0.60–1.66) | 0.999 |
Yes | Present | 64 (32.3) | 119 (22.7) | 1.86 (1.24–2.81) | 0.003 |
Yes | Null | 33 (16.7) | 36 (6.9) | 3.39 (1.95–5.91) | 0.000 |
Interaction | 1.83 (0.84–3.96) | 0.126 |
ORa adjusted for family income, maternal age, education level and prepregnancy BMI.
GSTs “null” if both GSTM1 and GSTT1 “null”, GSTs “present” if either GSTM1 or GSTT1 “present”.
% for distribution within the case and control groups respectively.